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Abstract
Background: The intrarenal natriuretic hormone dopamine (DA) is metabolised by catechol-O-
methyltransferase (COMT) and monoamine oxidase (MAO). Inhibition of COMT, as opposed to
MAO, results in a potent natriuretic response in the rat. The present study in anaesthetized
homozygous and heterozygous COMT gene deleted mice attempted to further elucidate the
importance of COMT in renal DA and sodium handling. After acute intravenous isotonic sodium
loading, renal function was followed.
Results: COMT activity in heterozygous mice was about half of that in wild type mice and was
zero in the homozygous mice. MAO activity did not differ between the genotypes. Urinary sodium
excretion increased 10-fold after sodium loading in wild type mice. In heterozygous and
homozygous mice, the natriuretic effects of sodium loading were only 29 % and 39 %, respectively,
of that in wild type mice. Arterial pressure and glomerular filtration rate did not differ between
genotypes. Baseline norepinephrine and DA excretions in urine were elevated in the homozygous,
but not in heterozygous, COMT gene deleted mice. Urinary DA excretion increased after isotonic
sodium loading in the wild type mice but not in the COMT gene deleted mice.
Conclusions: Mice with reduced or absent COMT activity have altered metabolism of
catecholamines and are unable to increase renal DA activity and produce normal natriuresis in
response to acute sodium loading. The results support the hypothesis that COMT has an important
role in the DA-mediated regulation of renal sodium excretion.
Background
Besides the well-known effects of dopamine (DA) in the
brain, this catecholamine also has specific effects in the
kidney [1]. In the kidney, DA is produced in proximal tu-
bular cells [2,3], and contributes to the natriuretic re-
sponse that follows sodium loading [4]. Thus, DA is an
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crine effects that are exerted mainly by inhibiting tubular
sodium transport [1]. The body sodium content is of cru-
cial importance for the volume of the extracellular fluid
(ECV), which, in turn, is closely related to the level of the
mean arterial blood pressure (MAP). Thus, sodium han-
dling is correlated to the setting of MAP. Defects in the re-
nal DA system may reduce the natriuretic response to
sodium loading, thereby leading to salt-sensitive hyper-
tension [5,6].
DA is metabolised by monoamine oxidase (MAO) and
catechol-O-methyl-transferase (COMT). The main metab-
olites are dihydroxyphenylacetic acid (DOPAC), formed
by MAO and, after further methylation by COMT, ho-
movanillic acid (HVA). Some of the DA is metabolised di-
rectly by COMT, forming 3-methoxytyramine (3-MT),
which then also forms HVA by an action of MAO. All
these metabolites are excreted into the urine, where the
predominant final metabolite is HVA [7].
Although the detailed regulation of DA-induced natriure-
sis remains to be elucidated, several possibilities have
been examined. We and others have shown in the rat that
COMT inhibition leads to a pronounced natriuresis [8–
12] and we have found that renal cortical COMT activity
is reduced during isotonic sodium loading [11]. This sug-
gests that COMT plays a role in the regulation of DA-in-
duced natriuresis.
On the basis of these considerations we subjected COMT
gene deleted mice and wild type mice to acute isotonic so-
dium loading with the aim of determining whether this
would disclose a difference in sodium and DA handling
between these genotypes.
Results
Control group (time control)
Urinary flow rate, DA, DOPAC and NE excretion and GFR
were stable throughout the experiment in all genotypes
(Table 1 and 2). Urine flow rate did not differ between the
genotypes in this basal state. The excretion of DA in the
urine tended to be higher in the HM than in the HT or WT
mice, but, this difference was not statistically significant in
a 2-way ANOVA. The urinary excretion of NE was higher
in the HM than in the HT or WT mice. MAP decreased
slightly at the end of the experiment in HT and HM mice
(Table 1). The excretion of DOPAC was found to be very
low in mice as compared to that in the rat (about 5 %,
[11]) and showed no difference between the genotypes
(Table 1). As pointed out in the discussion, the DOPAC
levels were close to the detection limit.
Table 1: Mean arterial blood pressure (MAP), urinary flow rate (UV) and urinary excretion of DA (UDAV), urinary excretion of DOPAC 
(UDacV) and norepinephrine (U NEV) in wild type and in heterozygous and homozygousCOMT gene deleted mice of the control 
groups. Kw = kidney weight. *p<0.05 vs WT (MAP) or vs WT and HT mice (UNEV).
C1 C2 E1 E2 E3 E4
MAP (mmHg)
Wild type 89±2 88±2 85±2 83±2 80±2 80±7
Heterozygous 90±3 88±3 86±3 82±3* 80±2* 83±2*
Homozygous 96±2 95±2 90±2 88±2 85±2* 82±2*
UV(µl·min-1·g-1 kw)
Wild type 1.82±0.30 1.87±0.20 1.84±0.21 2.29±0.25 2.64±0.31 2.69±0.57
Heterozygous 2.18±0.24 1.83±0.13 2.05±0.11 2.43±0.19 2.76±0.25 2.66±0.44
Homozygous 1.76±0.29 1.77±0.21 2.01±0.18 2.73±0.21 2.58±0.24 3.09±0.26
UDAV(ng·min-1·g-1 kw)
Wild type 3.17±0.67 4.31±0.80 3.62±0.81 3.91±0.86 3.77±0.78 3.80±1.67
Heterozygous 4.51±0.94 4.18±0.94 4.01±0.93 3.99±0.86 3.86±0.83 6.13±1.95
Homozygous 5.27±0.97 7.23±2.19 5.99±1.08 6.21±0.87 5.20±0.81 5.92±1.24
UDacV (ng·min-1·g-1 kw)
Wild type 0.25±0.09 0.27±0.11 0.23±0.11 0.20±0.07 0.18±0.04 0.22±0.08
Heterozygous 0.23±0.16 0.14±0.08 0.08±0.04 0.11±0.05 0.21±0.14 0.16±0.07
Homozygous 0.30±0.19 0.33±0.19 0.35±0.24 0.31±0.21 0.29±0.21 0.54±0.41
UNEV (ng·min-1·g-1 kw)
Wild type 3.01±0.77 3.33±0.79 3.09±0.80 2.59±0.67 2.33±0.61 1.35±0.10
Heterozygous 4.50±0.89 4.82±0.82 4.55±1.05 4.24±1.04 4.44±1.02 2.92±0.45
Homozygous 7.44±1.60* 8.12±1.72* 7.25±1.28* 7.45±1.29* 7.43±0.96* 8.53±0.47*Page 2 of 9
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Upon sodium loading the mean sodium excretion in-
creased 10-fold in WT mice (from 0.086 ± 0.02 to 0.87 ±
0.28 µmol·min-1·g-1 kw; p < 0.05; Table 3), whereas the
mean value increased 3.5-fold in HM mice (from 0.097 ±
0.02 to 0.34 ± 0.13 µmol·min-1·g-1 kw, ns) and 3-fold in
HT mice (from 0.08 ± 0.02 to 0.25 ± 0.11 µmol·min-1·g-
1 kw, ns). Urine flow rate increased in HM and WT mice
upon sodium loading. A similar trend was observed in HT
mice but this response did not reach statistical signifi-
cance.
The natriuretic responses in HT and HM mice in the last
period of the experiment (E4) thus amounted to only
29% and 39%, respectively, of the response in the WT
mice (p < 0.05, Fig. 1). GFR did not differ between the
genotypes or treatments (Table 2). During acute isotonic
sodium loading MAP decreased in all genotypes (Table 3).
The mean urinary DA excretion during the control periods
(C1-C2) was higher in the HM mice than in the wild type
and HT mice (p < 0.05; Fig. 2, Table 3). The urinary DA ex-
cretion increased in the WT mice after isotonic sodium
loading (from 3.17 ± 0.55 to 4.48 ± 0.80 ng·min-1·g-1
kw; p < 0.05; Fig. 2), whereas both the HM and the HT
Table 2: Glomerular filtration rate (GFR) in wild type and in heterozygous and homozygous COMT gene deleted mice in the control 
group and in the group subjected to isotonic sodium loading. C2 is at t = 60 min, just before the start of isotonic sodium loading, and E4 
is at t = 180 min just before the end of the experiment.
C2 E4
GFR (mlSmin-1·g-1 kw) CONTROL 
GROUP
Wild type 0.78±0.08 0.85±0.11
Heterozygous 0.87±0.13 0.70±0.06
Homozygous 0.84±0.21 0.85±0.12
GFR (ml·min-1·g-1 kw) SODIUM 
LOADING
Wild type 0.85±0.09 0.91±0.12
Heterozygous 0.84±0.07 1.16±0.05
Homozygous 0.85±0.10 0.76±0.06
Table 3: Mean arterial blood pressure (MAP), urinary flow rate (UV), urinary sodium (UNaV) and dopamine (UDA V) excretion in wild 
type, heterozygous and homozygous COMT gene deleted mice before (C1 and C2) and during (E1-E4) isotonic sodium loading. kw = 
kidney weight. *p < 0.05 vs C2 of the same genotype.
C1 C2 E1 E2 E3 E4
MAP (mmHg)
Wild type 97±3 95±3 91±3 86±3* 84±3* 90±4*
Heterozygous 93±2 90±2 86±1 81±1* 79±1* 76±3*
Homozygous 94±1 93±2 86±2 81±2* 77±2* 74±2*
UV (µl·min-1·g-1 kw
Wild type 1.90±0.18 1.99±0.28 2.26±0.30 3.34±0.34 5.66±0.89* 6.94±1.33*
Heterozygous 1.88±0.18 1.96±0.18 2.38±0.26 2.56±0.25 3.62±0.37 4.53±0.48
Homozygous 2.27±0.39 2.17±0.40 2.68±0.45 3.24±0.79 4.77±0.98* 6.53±1.40*
UNaV (µmol·min-1·g-1 kw)
Wild type 0.08 ± 0.02 0.07 ± 0.02 0.07 ± 0.01 0.14 ± 0.05* 0.39 ± 0.16* 0.87 ± 0.28*
Heterozygous 0.07 ± 0.01 0.08 ± 0.02 0.08 ± 0.01 0.07 ± 0.01 0.12 ± 0.04 0.25 ± 0.11
Homozygous 0.09 ± 0.02 0.05 ± 0.01 0.05 ± 0.01 0.06 ± 0.02 0.14 ± 0.06 0.34 ± 0.13
UDAV (ng·min-1·g-1 kw
Wild type 3.2 ± 0.5 3.4 ± 0.5 3.7 ± 0.6 4.4 ± 0.7 5.6 ± 1.1*
Heterozygous 3.4 ± 0.6 3.6 ± 0.5 3.7 ± 0.6 3.4 ± 0.5 3.8 ± 0.5
Homozygous 9.2 ± 2.8 8.5 ± 2.3 8.3 ± 2.5 6.7 ± 1.7 8.0 ± 2.6Page 3 of 9
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(change from 8.85 ± 2.55 to 8.32 ± 2.45 ng·min-1·g-1 kw
in HM and from 3.60 ± 0.52 to 3.44 ± 0.48 ng·min-1·g-1
kw in HT mice; Fig. 2). Note, however, that the baseline
urinary DA excretion was elevated prior to sodium load-
ing in HM. The urinary excretion of DOPAC and of NE
was not significantly changed after sodium loading in any
group (data not shown).
COMT and MAO activities
The COMT activity was measured in specimens of the re-
nal cortex, outer medulla and papilla from all animals.
The basal level of specific COMT activity in WT mice was
highest in the cortex (216 ± 21 pmol·mg-1·min-1) and
lower in the outer medulla (54 ± 17 pmol·mg-1·min-1)
and the papilla (56 ± 9 pmol·mg-1·min-1).
There was a tendency (p = 0.10) towards a decrease in
COMT activity in the renal cortex after isotonic sodium
loading (173 ± 14 pmol·mg-1·min-1). The COMT activity
did not change in the outer medulla (64 ± 11 pmol·mg-
1·min-1) nor in the papilla (62 ± 6 pmol·mg-1·min-1).
Under control conditions the COMT activity in HT mice
was about half of that in WT mice namely 118 ± 12
pmol·mg-1·min-1 in the cortex and 31 ± 1 pmol·mg-
1·min-1 in the papilla and even lower in the outer medul-
la (19 ± 5 pmol·mg-1·min-1). As expected, the COMT ac-
tivity was zero in all parts of the kidney in HM mice. The
MAO activities did not differ significantly between the
three genotypes, nor did these activities change after sodi-
um loading (Table 4). Thus, it seems as if no compensato-
ry effect on MAO activity occurred in animals with
reduced or no COMT activity.
Discussion
This study in COMT gene deleted mice was undertaken to
further elucidate the role of COMT in the regulation of re-
nal DA and sodium handling. In previous studies in rats
we and others have demonstrated that pharmacological
inhibition of COMT results in a potent D1-like receptor-
mediated natriuretic response [8–12]. Furthermore, we
have found in rats that renal cortical COMT activity is re-
duced during isotonic sodium loading [11]. The results of
the present study show that mice with reduced or absent
COMT activity are unable to increase the renal DA excre-
tion from whatever baseline level and to produce normal
natriuresis in response to acute sodium loading. The re-
sults support the hypothesis that COMT plays an impor-
tant role in the DA-mediated regulation of renal sodium
excretion.
During moderate isotonic sodium loading in rats, up to
60 % of sodium excretion is mediated by D1-like receptors
[6,11,13,14]. The contribution of the dopaminergic sys-
tem to natriuresis in mice has been reported in one study
previously [14]. The study found that disruption of the D3
receptor gene attenuated the ability of homozygous mice
to respond with natriuresis upon a similar saline load as
given in the present study. Since we in the present study
have not tested the dependency of the natriuresis on DA
receptors, we cannot categorically state that the blunted
natriuretic response in COMT gene deleted mice after
Figure 1
Mean urinary sodium excretion (UNaV) during control treat-
ment and in response to isotonic sodium loading in wild type
mice and in heterozygous and homozygous COMT gene
deleted mice. *p < 0.05 vs control treatment in the same gen-
otype. kw = kidney weight.
Figure 2
Mean urinary dopamine excretion (UDAV) during control
periods (C1-C2) and in response to isotonic sodium loading
(E1-E4) in wild type, heterozygous and homozygous COMT
gene deleted mice. *p < 0.05 vs the same genotype. #p < 0.05
vs wild type and heterozygous. kw = kidney weight.Page 4 of 9
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The wild type mice, however, responded with an in-
creased DA activity after sodium loading, as has previous-
ly been demonstrated in rats [11–13,16]. The fact that the
homozygous and heterozygous mice did not respond
with an increased DA activity after sodium loading strong-
ly indicates a renal dopaminergic defect in these animals.
COMT metabolises other substances involved in sodium
excretion besides DA, such as NE, and urinary NE excre-
tion was indeed increased in the homozygous but not in
the heterozygous mice compared to their wild type litter-
mates. NE is considered to act antinatriuretically via
adrenoceptors [17,18] and its urinary excretion is de-
creased after sodium loading in normal rats [19]. In the
present study urinary NE excretion did not change in any
of the genotypes after sodium loading. Furthermore, the
renal α1-adrenoceptor expression is similar between the
genotypes (data not shown). This would suggest that NE
plays only a minor role, if any, in the regulation of the
natriuresis provoked in this experimental setting.
On the basis of our previous results, we hypothesise that
COMT is necessary for upregulating DA activity in re-
sponse to sodium loading, thereby affecting renal sodium
handling. In the wild type mice, as in normal rats
[9,16,20], urinary DA excretion increased in response to
isotonic sodium loading. The cortical COMT activity
showed a tendency to decrease, an effect which we have
previously observed in rats during sodium loading [11].
This may well contribute to an increase in DA activity.
These changes in renal DA regulation in wild type mice
were accompanied by a 10-fold increase in urinary sodi-
um excretion.
In the heterozygous COMT gene deleted mice the cortical
COMT activity was about half of that in the wild type
mice. The baseline urinary DA and NE excretions were
similar to those in the wild type mice, suggesting that the
reduced COMT activity is still sufficient to metabolise DA
and NE. However, during isotonic sodium loading, the
heterozygous mice, as opposed to the wild type mice, were
unable to increase the DA excretion and the natriuretic re-
sponse was only 29% of that in the wild type mice. This
would again suggest an important regulatory defect in
these animals due to reduced COMT function.
In the homozygous COMT gene deleted mice the baseline
urinary DA and NE excretions were elevated as a result of
the reduced ability to metabolise these catecholamines.
During isotonic sodium loading these animals failed to
respond with a further elevation in DA activity (beyond
basal values) and the natriuretic response was only 39%
of that in the wild type mice. These results together
strengthen the hypothesis that COMT has an important
role in regulating DA activity in response to sodium load-
ing and thereby affecting renal sodium handling.
The urinary excretion of DOPAC in mice was found to be
very low and very close to the detection limit of the HPLC
system thereby restricting the conclusions that can be
drawn regarding genotype differences and the response to
sodium loading. The low levels are in contrast to our pre-
vious observations in rats that urinary DOPAC excretion
was larger than DA excretion [4,10,11]. This implies a dif-
ference in the handling of DA metabolism between mice
and rats. A comparison of the renal enzyme activities be-
tween mice (present study) and rats [11] has shown that
the COMT activity is similar, while the MAO activity is sig-
nificantly weaker in mice than in rats. MAO forms the
main metabolite DOPAC from DA. It is therefore obvious
that low MAO activity will result in low DOPAC genera-
tion, analogously to pharmacological MAO inhibition
[11]. The renal MAO activity in mice is about 10 % of that
in the rat and the corresponding urinary DOPAC excre-
tion is about 5 % [11].
The conclusions that can be drawn from experiments with
genetically modified animals are limited. Compensatory
mechanisms are likely to develop. Changes in gene ex-
pression might have effects on other systems during early
development, and phenotypic differences may not always
be obvious. However, the expressions of D1-like and D2-
like receptors are not changed in the brain or in renal tis-
sue in COMT gene deleted mice as compared to the wild
type mice (Garcia and Männistö, unpublished results,
2001). Furthermore, we have found that the density of α1-
Table 4: Renal cortical monoamine oxidase (MAO) activity in wild type (WT) and in heterozygous (HT) and homozygous (HM) COMT 
gene deleted mice during control treatment and after isotonic sodium loading.
WT HT HM
MAO activity (pmol·mg-1·min-1)
CONTROL GROUP 16.9±4.3 15.1±3.9 9.6±2.3
SODIUM LOADING 16.9±4.8 13.1±2.9 15.4±5.4Page 5 of 9
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three genotypes (data not shown). Thus, it is not likely
that the difference in natriuretic response is due to chang-
es in the DA or adrenoceptor density. However, the func-
tionality of these receptors has not been studied.
Furthermore, in a recent study by Houtari et al. [21] using
the COMT gene deleted mice it was found that no com-
pensatory changes in protein levels of catecholamine-syn-
thesizing (tyrosine hydroxylase, dopa decarboxylase,
dopamine-beta-hydroxylase) and catecholamine-metabo-
lising enzymes (MAO-A/B, phenylsulfotransferase) had
occurred.
Acute pharmacological COMT inhibition in rats results in
an acute elevation of dopamine levels which results in an
acute elevation of sodium excretion [8–10]. In the geneti-
cally COMT inactivated mice the chronically elevated ba-
sal dopamine levels does not result in a chronically
elevated basal sodium excretion as compared with the
wildtype mice. This may seem as inconsistent regarding
the relationship between basal urinary dopamine and so-
dium excretion. It is, however, important to acknowledge
that longterm sodium excretion will always depend and
be in balance with that which has been ingested. It seems
primarily to be the changes in dopamine levels from
whatever baseline level which will cause a change in the
excretion of sodium and not the baseline level per se.
A defect in the renal DA system resulting in a reduced abil-
ity to respond with natriuresis after sodium loading may
lead to salt-sensitive hypertension [5,6]. Defects in the DA
system have been found in association with some forms
of hypertension in rats [6,22,23] and mice [15,24]. In the
present study we found no differences in MAP between
the genotypes, either under control conditions or after so-
dium loading. It is difficult, however, to compare MAP in
gas anaesthetised mice, since one of the determinants of
the level of isoflurane used is MAP. Thus, to correctly elu-
cidate this issue, measurements of MAP in non-anaesthe-
tised mice using the telemetric method are preferred.
The tonic control over renal vascular resistance exerted by
the renin-angiotensin system has been shown to be great-
er in mice than in rats [25]. The reduced MAP after sodium
loading seen in all genotypes in the present study may be
secondary to reduced levels of angiotensin II, resulting in
vasodilation. Such a suggestion would be in line with the
results of Traynor & Schnermann [26] showing a major
contribution of the renin-angiotensin system to the va-
sodilation caused by isotonic sodium loading. The activity
of the renin-angiotensin system in the different genotypes
used in the present study is unknown and renders further
investigations.
We have observed in an earlier study in rats that after acute
isotonic sodium loading, cortical COMT activity was re-
duced. A similar trend (p = 0.10) was seen in the sodium-
loaded wild type mice in this study. It is therefore possible
that at least part of the increased DA activity noted after
isotonic sodium loading is due to reduced degradation of
DA. The MAO activity was not altered after isotonic sodi-
um loading in wild type mice which is in line with our
previous study in rats [11]. It is also worthy of mention
that in the rat it has been demonstrated that both COMT
inhibitor and the atrial natriuretic peptide (ANP) result in
translocation of the D1-like receptor to the cell membrane
[26,27]. This may represent another way of regulating DA-
mediated natriuresis, especially since it is known that ANP
is released in response to isotonic sodium loading [4].
Conclusions
The present study shows that mice with reduced or absent
COMT activity are unable to increase the DA activity and
to produce normal natriuresis in response to sodium
loading. The results support the hypothesis that COMT
plays an important role in the DA-mediated regulation of
renal sodium excretion.
Materials and methods
Production and genotyping of COMT gene deleted mice
The COMT gene-deleted strain was produced as previous-
ly described [28]. In brief, the gene encoding COMT was
disrupted by replacing part of the fragment with a cassette
including the neo gene. The construct was introduced into
the genome of embryonic stem (ES) cells of 129/Sv mice
by means of homologous recombination. ES cells with
positive homologous recombination were selected by ne-
omycin resistance (~15 %) and were injected into C57B6
early mouse embryos in the blastocyst stage. Chimeric
males (mice containing both cells from the microinjected
ES cell and the host embryo) were mated with C57B6 fe-
males and in cases where the injected recombinant ES
cells had contributed to the germ line of the chimeric
mouse, the mating resulted in heterozygous (HT) 129/Sv/
C57B6 offspring with respect to the target gene. HT ani-
mals were mated and mice of all three genotypes were ob-
tained (F1 generation). Each mouse was then typed by
southern blot analysis [28]. DNA from tail biopsies was
extracted and digested with EcoRV, and fragments were
separated on a gel. The fragments were blotted with two
different radioactively marked probes and on the exposed
films an 11.5 kb fragment was seen in wild type (WT)
samples, a 3.5 kb signal in homozygous (HM) genotypes
and both of these in HT genotypes.
Animal procedures
The experiments were approved by the Ethics Committee
for Animal Experimentation at the University of Uppsala.
The study was performed on a total of 66 mice: 11 WT, 13Page 6 of 9
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31.0 ± 0.9, 30.8 ± 1.0 and 30.4 ± 1.3 g, respectively, and
10 WT, 15 HT and 9 HM female such mice, weighing 23.7
± 0.5, 24.4 ± 0.5 and 23.0 ± 0.3 g, respectively. Up to the
day of the experiment all animals had free access to tap
water and standardised chow (R3, Ewos, Södertälje, Swe-
den) containing 0.3 % sodium, 0.8 % potassium and 21
% protein. Anaesthesia was induced by placing the mice
in a polystyrene box with isoflurane flowing through it
(ForeneR, Abbott Scandinavia AB, Kista, Sweden). After
induction, the animals were placed in the supine position
on a thermostatically controlled surgical table to maintain
the body temperature at 37°C and a breathing mask was
placed over the head. The inhalation gas contained ~2 %
isoflurane in air with 37.5 % O2 during surgery and the
amount of isoflurane was subsequently adjusted to main-
tain the respiratory rate and MAP. Polyethylene catheters
were inserted into the right femoral vein and artery, the
former for infusion of isotonic saline (0.15 M NaCl) and
the latter for continuous monitoring of mean arterial
blood pressure (MAP) and for blood sampling. The uri-
nary bladder was catheterised through a suprapubic inci-
sion for urine collection. After the experimental
procedures described below and excision of the kidneys,
all animals were euthanised by an intravenous injection
of saturated KCl.
Protocol
After completion of the surgical procedures, the mice re-
ceived an intravenous bolus infusion of 0.08 ml isotonic
saline to replace fluid losses during surgery. This bolus
dose contained 0.5 µCi of [3H]methoxy-inulin. A mainte-
nance infusion of 0.15 M NaCl containing 2.5 µCi·ml-1
of inulin was administered at a rate of 0.5 ml·h-1. After a
45 min stabilisation period and 60 min of control sam-
pling (2 × 30 min, C1-C2), the mice were divided into two
groups. One group was given isotonic saline (0.15 M Na-
Cl, n = 11 WT, n = 14 HT and n = 8 HM) continuously at
a rate of 1.5 ml·h-1 (ECV expansion, 5% of body weight)
during four 30-min observation periods (E1-E4). The oth-
er group, the control animals, (n = 10 WT, n = 12 HT and
n = 9 HM) received isotonic saline at the maintenance in-
fusion rate (0.5 ml·h-1) throughout the study (E1-E4).
Because of the small blood volume in the mouse (~1.5
ml), blood samples for GFR estimation (~15 µl) were only
drawn at two time points during the experiment (C2 and
E4). Before the animal was killed, the kidneys were ex-
cised, placed on carbon-dioxide ice and sliced under a mi-
croscope into sections of cortex, outer medulla and
papilla; the pieces were frozen in a mixture of alcohol and
carbonic ice and subsequently stored at -70°C pending as-
say of COMT and MAO activities.
Urine analysis
The urine volumes were measured gravimetrically. The
urinary sodium concentration (UNa) was determined by
flame photometry (FLM3, Radiometer, Copenhagen,
Denmark). For assay of DA, DOPAC and norepinephrine
(NE), urine samples were immediately transferred to pol-
yethylene vials containing 1 ml 0.4 M perchloric acid
(PCA), 0.1 ml 10 % EDTA-Na2 and 0.05 ml 5 % Na2S2O5
and immediately frozen to -70°C. The DA, DOPAC and
NE contents were measured electrochemically following
alumina adsorption and ion-pair, reverse-phase high-per-
formance liquid chromatography (HPLC, [29]). An inter-
nal standard (3,4-dihydroxybenzylamine) was used and
all values were corrected for its recovery. Recovery through
the alumina extraction step was determined from aqueous
mixtures of catecholamines.
The amount of [3H]methoxy-inulin in samples of plasma
and urine was determined in a liquid scintillation coun-
ter. The glomerular filtration rate (GFR) was estimated
from the clearance of [3H]methoxy-inulin (Cin) according
to the equation:
Cin = (Uin · V) / Pin
where Uin and Pin are the urinary and plasma concentra-
tions, respectively, of inulin and V is the urine flow rate.
Measurements of COMT and MAO activities
COMT and MAO activities were measured in renal sec-
tions of cortex, outer medulla and papilla (prepared as de-
scribed under Protocol).
COMT activity was measured by electrochemical detec-
tion of the reaction products formed from the substrate
dihydroxybenzoic acid by COMT using HPLC, as previ-
ously described in detail [30,31]. In short, 100 µl enzyme
preparation was incubated for 30 min at 37°C in the pres-
ence of 240 µM dihydroxybenzoic acid, 5 mM MgCl2 and
200 µM SAM in 100 mM sodium phosphate buffer, pH
7.4. The reaction was terminated with ice-cold PCA (4 M,
25 µl) and centrifuged for 10 min at 5530 × g at 4°C. The
supernatants were subjected to HPLC analysis for vanillic
acid and isovanillic acid.
Determination of MAO activity was based on the detec-
tion of hydrogen peroxide in a horseradish peroxidase-
coupled reaction using 10-acetyl-3,7-dihydroxy-phenox-
azine, a probe for hydrogen peroxide [32,33]. An Am-
plexTM Red Monoamine Oxidase Assay Kit (A-12214,
Molecular Probes) was used for measurement of the activ-
ity. One hundred microlitres of supernatant was mixed
with 100 µl reaction buffer containing 50 mM phosphate
buffer, pH 7.4, horseradish peroxidase 2 U·ml-1, 400 µM
10-acetyl-3,7-dihydroxy-phenoxazine and 2 mM p-Page 7 of 9
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crease in fluorescence intensity (excitation 530/25 nm,
emission 645/40 nm) was measured with a fluorescence
microplate reader, with resorufin used as standard.
Statistical analysis
All data are presented as means ± 1 standard error of the
mean (SEM). Differences within and between groups were
tested for significance by two-way analysis of variance
(ANOVA) followed by the Tukey test (STATISTICA,
StatSoft, Tulsa, OK, USA) or by an unpaired t-test. A p val-
ue of less than 0.05 was adopted as statistically significant.
No gender differences in excretory data or enzymatic ac-
tivities were found, and results for males and females of
the same genotype and treatment group were therefore
pooled. Mice with an MAP below 70 mmHg were exclud-
ed from the study.
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